Skip to main content
Moleculin Biotech, Inc. logo

Moleculin Biotech, Inc. — Investor Relations & Filings

Ticker · MBRX ISIN · US60855D2009 LEI · 549300IB1TLJZCHEO353 US Manufacturing
Open in API
Filings indexed 784 across all filing types
Latest filing 2016-08-09 Regulatory Filings
Country US United States of America
Listing US MBRX

About Moleculin Biotech, Inc.

https://moleculin.com/

Moleculin Biotech, Inc. is a late-stage clinical pharmaceutical company focused on developing a portfolio of therapeutic candidates for highly resistant cancers and viruses. The company's lead drug candidate is Annamycin, a next-generation liposomal anthracycline designed to be non-cardiotoxic and to circumvent multidrug resistance. Annamycin is being advanced in a pivotal Phase 3 clinical trial for the treatment of relapsed or refractory acute myeloid leukemia (AML). The company's development pipeline also includes other drug candidates targeting hard-to-treat tumors.

Recent filings

Filing Released Lang Actions
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce unscheduled material events or corporate changes. The text specifically mentions an 'Other Events' section describing a press release about extending a research agreement. There are no financial statements or detailed financial data included, only a reference to a press release as an exhibit. The document length is short (2498 characters), and it primarily serves as an announcement rather than a full report. Therefore, it does not qualify as an Annual Report (10-K), Interim Report (IR), or Earnings Release (ER). It is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2016-08-09 English
OWNERSHIP DOCUMENT
Director's Dealing
2016-08-09 English
OWNERSHIP DOCUMENT
Director's Dealing
2016-08-09 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce unscheduled material events or corporate changes. The text indicates it is a short filing (2617 characters) reporting the issuance of a press release about data presented at a symposium. It includes no financial statements or detailed financial data, only a reference to the press release as an exhibit. The document does not contain an annual or quarterly report, audit information, or earnings release. It is primarily an announcement of an event and a press release filing. According to the rules, such short filings announcing events or press releases without substantive financial data or detailed reports fall under Regulatory Filings (RNS).
2016-08-02 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce unscheduled material events or corporate changes. The text mentions an "Other Events" section describing a press release about validation of an engineering run, and includes an exhibit which is the press release itself. There are no financial statements or detailed financial data presented. The document length is short (2489 characters), and it primarily serves as an announcement of an event rather than a detailed financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous SEC filings that do not fit other specific categories.
2016-07-22 English
S-8
Share Issue/Capital Change Classification · 95% confidence The document is a Form S-8 Registration Statement filed with the SEC, which is used to register securities to be offered under employee benefit plans such as stock option plans. It includes detailed information about the stock plan, registration fee calculation, indemnification provisions, and references to other filings. This type of filing is related to share issuance under employee plans and is not a financial report, earnings release, or management discussion. It is specifically about registering shares for issuance under a stock plan, which aligns with announcements regarding share issues or capital changes. Therefore, the appropriate classification is Share Issue/Capital Change (SHA). The document length and content confirm it is the actual registration statement, not just an announcement or a certification, so SHA is the best fit.
2016-07-21 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.